P3 Health Other Liab Over Time
| PIII Stock | USD 0.24 0.03 14.29% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out P3 Health Performance and P3 Health Correlation. PIII |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.86) | Revenue Per Share 11.552 | Quarterly Revenue Growth 0.152 | Return On Assets (0.12) | Return On Equity (0.41) |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Liab Analysis
Compare P3 Health Partners and related stocks such as Aesthetic Medical Intl, Sonida Senior Living, and Acadia Healthcare Other Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SNDA | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 23.8 M | 3.7 M | 3.7 M | 113 K | 113 K | 101.7 K | 96.6 K |
| ACHC | 1.9 M | 5.3 M | 12.4 M | 19.3 M | 43.5 M | 102.5 M | 243.4 M | 246.8 M | 234.6 M | 225.7 M | 183.4 M | 184.9 M | 206.8 M | 237.8 M | 144.7 M |
| CCEL | 1.3 M | 10.7 M | 11 M | 11.8 M | 13.2 M | 14 M | 17.2 M | 26 M | 28.6 M | 29.6 M | 34.8 M | 38 M | 38 M | 43.7 M | 45.9 M |
| CYH | 15.2 M | 950 M | 1 B | 977.3 M | 1.7 B | 2.2 B | 1.9 B | 1.4 B | 1 B | 1.1 B | 1.6 B | 1 B | 998 M | 1.1 B | 940.3 M |
| LFST | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 98.4 M | 107.9 M | 41.5 M | 47.7 M | 70.9 M |
| AGL | 360.3 M | 360.3 M | 360.3 M | 360.3 M | 360.3 M | 360.3 M | 360.3 M | 360.3 M | 360.3 M | 360.3 M | 394.1 M | 188.6 M | 73.4 M | 66.1 M | 62.8 M |
| BKD | 190 M | 276.2 M | 272.1 M | 330.1 M | 524.2 M | 552.9 M | 578.9 M | 509.6 M | 478.4 M | 184.4 M | 198 M | 86.8 M | 85.8 M | 98.7 M | 93.8 M |
| INNV | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 4.1 M | 3 M | 3 M | 7.2 M | 10.7 M | 18.9 M | 7.3 M | 7.3 M | 8.4 M | 7.6 M |
| USPH | 273 K | 1.6 M | 1.6 M | 1.7 M | 1.7 M | 2.3 M | 18.1 M | 13.7 M | 12 M | 10.2 M | 12.3 M | 21.7 M | 34.3 M | 39.5 M | 41.5 M |
| EHAB | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 63.2 M | 30.5 M | 27.4 M | 43.5 M |
| ENSG | 17.5 M | 36.9 M | 41.1 M | 38.7 M | 37.4 M | 41.9 M | 53.1 M | 73.6 M | 77.3 M | 63.4 M | 102.1 M | 96.4 M | 116.8 M | 134.3 M | 141 M |
| SEM | 52.3 M | 64.9 M | 68.5 M | 91.9 M | 92.9 M | 351.9 M | 335.6 M | 270.6 M | 312.8 M | 249.6 M | 301.1 M | 249.2 M | 275.9 M | 317.3 M | 200.2 M |
| EHC | 4.1 M | 133.2 M | 136.7 M | 142.2 M | 136.3 M | 144.6 M | 160 M | 185.3 M | 205.2 M | 159.9 M | 266.8 M | 259.9 M | 257.2 M | 231.5 M | 172.7 M |
P3 Health Partners and related stocks such as Aesthetic Medical Intl, Sonida Senior Living, and Acadia Healthcare Other Liab description
My Equities
My Current Equities and Potential Positions
| P3 Health Partners | PIII |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Illinois; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.24
Check out P3 Health Performance and P3 Health Correlation. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
P3 Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.